RedHill Biopharma Ltd - Company Profile
Powered by
All the data and insights you need on RedHill Biopharma Ltd in one report.
- Save hours of research time and resources with
our up-to-date RedHill Biopharma Ltd Strategy Report
- Understand RedHill Biopharma Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
RedHill Biopharma Ltd (RedHill) is a specialty biopharmaceutical company that develops and commercializes therapeutics for gastrointestinal (GI) diseases and cancer. The company’s commercial product portfolio consists of branded prescription drugs including a combination of omeprazole, amoxicillin and rifabutin omeprazole; naloxegol; and rifamycin. RedHill is investigating its pipeline candidates for the treatment of Crohn's disease, non-tuberculous mycobacterial infection (NTM) infections, gastroenteritis, gastritis, irritable bowel syndrome with diarrhea (IBS-D), bowel cleanser, cancer and novel coronavirus disease (COVID-19). The company has a subsidiary in the US. RedHill is headquartered in Tel Aviv, Israel.
RedHill Biopharma Ltd premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Prescription Drugs: | Talicia |
A combination of Omeprazole, Amoxicillin and Rifabutin | Movantik |
Naloxegol | Aemcolo |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
Competitor Comparison
Key Parameters | RedHill Biopharma Ltd | Hayat Pharmaceutical Industries | BioLineRx Ltd | SciSparc Ltd | Notable Labs Ltd |
---|---|---|---|---|---|
Headquarters | Israel | Jordan | Israel | Israel | United States of America |
City | Tel Aviv-Yafo | Amman | Modiin | Tel Aviv-Yafo | Foster City |
State/Province | - | - | - | - | California |
No. of Employees | 53 | 191 | 79 | 3 | 16 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Dror Ben-Asher | Chairman; Chief Executive Officer | Executive Board | 2011 | 57 |
Rick D. Scruggs | Chief Commercial Officer; Director | Executive Board | 2020 | 63 |
Razi Ingber | Chief Financial Officer | Senior Management | 2023 | 39 |
Gilead Raday | Chief Operating Officer | Senior Management | 2016 | 48 |
Kristin Comer | Chief Compliance Officer; Vice President; General Counsel | Senior Management | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer